Werbung
Werbung

AORT

AORT logo

Artivion, Inc.

44.22
USD
Gesponsert
-0.63
-1.42%
09. Jan., 10:37 UTC -5
Offen

AORT Ergebnisberichte

Positives Überraschungsverhältnis

AORT übertreffen die 27 der letzten 39Schätzungen.

69%

Nächster Bericht

Datum des nächsten Berichts
23. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$118.75M
/
$0.08
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+6.61%
/
+33.33%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+22.03%
/
-120.51%

Artivion, Inc. earnings per share and revenue

On 06. Nov. 2025, AORT reported earnings of 0.06 USD per share (EPS) for Q3 25, beating the estimate of 0.01 USD, resulting in a 242.86% surprise. Revenue reached 111.39 million, compared to an expected 112.65 million, with a -1.12% difference. The market reacted with a -5.54% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of 0.08 USD, with revenue projected to reach 118.75 million USD, implying an increase of 33.33% EPS, and increase of 6.61% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06. Jan. 2026 For Q2 26
Estimate
-$0.10
Aktuell
$0.00
Überraschung
+100.00%
FAQ
For Q3 2025, Artivion, Inc. reported EPS of $0.06, beating estimates by 242.86%, and revenue of $111.39M, -1.12% below expectations.
The stock price moved down -5.54%, changed from $47.50 before the earnings release to $44.87 the day after.
The next earning report is scheduled for 23. Feb. 2026.
Based on 9 analysts, Artivion, Inc. is expected to report EPS of $0.08 and revenue of $118.75M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung